This story was first published in digitalhealth.net
NICE approves irritable bowel syndrome drug
A £3 a day drug for irritable bowel syndrome has been approved by NICE.
The drug, Truberzi, has been recommended for routine funding on the NHS to treat patients with irritable bowel syndrome and diarrhoea (IBS-D).
Truberzi, also known as eluxadoline, will be routinely available for patients who have not responded to or cannot take other treatments.
The drug, made by Allergen, works by binding to certain receptors in the digestive system to slow down the movement of food through the gut. This helps to relieve associated stomach cramps and the urgency for the person to go to the toilet.
Truberzi will be available for patients alongside existing drug and psychological treatments for IBS-D. These can include drugs that stop spasms in the gut or hypnotherapy.
NICE has recommended the drug for patients with IBS-D to be offered only in secondary care and as long as it is stopped after four weeks if the treatment is unsuccessful.
Carole Longson, director of the centre for health technology evaluation at NICE, said: “IBS-D can significantly impact a person’s quality of life, sometimes leading to anxiety and affecting their daily activities. The committee heard that having this treatment available when others no longer work will be welcomed by patients.
“Truberzi addresses multiple symptoms of IBS-D and works in a different way compared to existing treatments, and we are pleased to be able to recommend it as an additional option for treating IBS-D.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
